Get started
Benitec Biopharma Inc.Benitec Biopharma Inc.Benitec Biopharma Inc.

Benitec Biopharma Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

BNTC chart

Key stats

Market capitalization
‪12.39 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−10.90USD
Net income
‪−19.56 M‬USD
Revenue
‪75.00 K‬USD
Shares float
‪2.42 M‬
Beta (1Y)
1.47

About Benitec Biopharma Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Jerel A. Banks
Website
benitec.com
Headquarters
Hayward
Employees (FY)
18
Founded
2019
ISIN
US08205P2092
FIGI
BBG00R712L56
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firms' proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on November 22, 2019 and is headquartered in Hayward, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BNTC is 4.80 USD — it has increased by 0.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Benitec Biopharma Inc. stocks are traded under the ticker BNTC.
Benitec Biopharma Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Benitec Biopharma Inc. has a max estimate of 10.00 USD and a min estimate of 10.00 USD.
BNTC earnings for the last quarter are −2.76 USD whereas the estimation was −0.51 USD which accounts for −441.18% surprise. Estimated earnings for the next quarter are −0.39 USD. See more details about Benitec Biopharma Inc. earnings.
Benitec Biopharma Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪9.50 K‬ USD.
Yes, you can track Benitec Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BNTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Benitec Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
BNTC reached its all-time high on Aug 5, 2015 with the price of 2409.01 USD, and its all-time low was 1.86 USD and was reached on Aug 9, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 18.00 employees. See our rating of the largest employees — is Benitec Biopharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Benitec Biopharma Inc. EBITDA is ‪−21.52 M‬ USD, and current EBITDA margin is ‪−24.93 K‬%. See more stats in Benitec Biopharma Inc. financial statements.